Scientists performed scRNA and scATAC-seq in COVID-19 patients with and without TET2-mutated clonal hematopoiesis reasoning that the inflammation from COVID-19 may highlight critical downstream transcriptional targets of TET2 mutations.
[Cancer Discovery]
